Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (HLTC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to $47.1 million.

  • National Healthcare Properties' Cash & Equivalents rose 4321.93% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year increase of 4321.93%. This contributed to the annual value of $21.7 million for FY2024, which is 5334.53% down from last year.
  • Latest data reveals that National Healthcare Properties reported Cash & Equivalents of $47.1 million as of Q3 2025, which was up 4321.93% from $47.1 million recorded in Q2 2025.
  • National Healthcare Properties' Cash & Equivalents' 5-year high stood at $74.1 million during Q1 2021, with a 5-year trough of $21.7 million in Q4 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $46.7 million (2021), whereas its average is $47.2 million.
  • Per our database at Business Quant, National Healthcare Properties' Cash & Equivalents tumbled by 6378.1% in 2021 and then skyrocketed by 14898.15% in 2025.
  • National Healthcare Properties' Cash & Equivalents (Quarter) stood at $59.7 million in 2021, then dropped by 10.18% to $53.7 million in 2022, then decreased by 13.5% to $46.4 million in 2023, then crashed by 53.35% to $21.7 million in 2024, then skyrocketed by 117.34% to $47.1 million in 2025.
  • Its Cash & Equivalents stands at $47.1 million for Q3 2025, versus $47.1 million for Q2 2025 and $71.4 million for Q1 2025.